SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Jul 24, 2013
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: July 24, 2013 · CIK: 0001430306 · Accession: 0001144204-13-040931
AI Filing Summary & Sentiment
File numbers found in text: 333-188547
Show Raw Text
CORRESP
1
filename1.htm
Roth Capital Partners, LLC
National Securities Corporation
888 San Clemente Drive
120 Broadway, 27th Floor
Newport Beach, CA 92660
New York, NY 10271
July 24, 2013
VIA EDGAR
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Adam Turk, Esq.
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form
S-1
File No. 333-188547
Ladies and Gentlemen:
The undersigned hereby
join in the request of the Company to withdraw the request for acceleration dated July 22, 2013, of the effective date of the registration
statement referred to above that was requested to become effective at 4:00 p.m., Washington D.C. time, on Wednesday, July
24, 2012, or as soon thereafter as practicable.
Roth Capital Partners, LLC
NATIONAL SECURITIES CORPORATION
By:
/s/ Aaron Gurewitz
By:
/s/ Jonathan Rich
Name:
Aaron Gurewitz
Name:
Jonathan Rich
Title:
Head of Equity Capital Markets
Title:
Head of Investment Banking